课题基金 / 基金详情

More Complete Assessment of DNA Variation in Age-Related Macular Degeneration

More Complete Assessment of DNA Variation in Age-Related Macular Degeneration
更全面地评估年龄相关性黄斑变性中的 DNA 变异
批准号:
8206182
负责人:
Goncalo Abecasis
金额:
$119.51万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2015-08-31

项目摘要

项目成果

Goncalo Abecasis的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):该提案建立在密歇根大学和宾夕法尼亚大学科学家之间积极和富有成效的合作基础上。该研究小组为我们理解黄斑变性的遗传学以及为黄斑变性和其他疾病的基因组研究提供一系列统计方法和分析工具做出了贡献。视网膜相关性黄斑变性(AMD)是一种进行性神经退行性疾病,是老年人致盲的主要原因。黄斑变性引起的视力丧失目前是不可逆的。在过去的几年里,通过SNP基因分型研究,我们对导致黄斑变性的分子机制的理解取得了很大进展,这些研究集中在一类容易获得的常见DNA序列变异上。在这里,我们建议使用DNA测序和基因分型技术的进步,更系统地评估DNA序列变异的作用,年龄相关性黄斑变性的易感性。我们的研究团队不仅包括临床专业知识和对黄斑变性的理解,还包括高通量遗传学和基因组学以及尖端统计和计算方法的开发和应用方面的专业知识。通过深度外显子组重测序和低通全基因组测序的组合,我们建议在3,000个个体中表征遗传变异,并评估> 20 M遗传变异对疾病易感性的贡献,不仅包括常见的SNP,还包括罕见的SNP,短插入缺失多态性和较大拷贝数的变异。我们的方法将产生新的黄斑变性易感基因座,并提高我们对以前涉及的基因座中疾病易感性的分子机制的理解。 公共卫生相关性:视网膜相关性黄斑变性(AMD)是一种进行性神经退行性疾病,是老年人致盲的主要原因。黄斑变性引起的视力丧失目前是不可逆的。以前对年龄相关性黄斑变性的遗传学研究集中在一类容易获得的DNA序列变异上。我们已经组建了一个专家团队,研究年龄相关性黄斑变性的临床特征、DNA序列变异的分析方法和工具以及相关的计算问题,并建议更彻底地评估DNA序列变异对疾病易感性的贡献。我们希望我们的研究将导致新的疾病易感性变体,并更好地理解导致疾病的分子变化。这些知识将有助于开发新的治疗方法,并制定早期诊断和预防疾病的策略。
英文摘要
DESCRIPTION (provided by applicant): This proposal builds on active and productive collaboration between scientists at the University of Michigan and at the University of Pennsylvania. The research team has made several contributions both to our understanding of the genetics of macular degeneration and to the array of statistical methods and analytical tools available for genomic studies of macular degeneration and other disorders. Age-related macular degeneration (AMD) is a progressive neurodegenerative disease and the major cause of blindness among the elderly. Loss of vision caused by macular degeneration is currently irreversible. In the past several years, great progress has been made in our understanding of the molecular mechanisms that lead to macular degeneration through SNP genotyping studies, which focus on an easily accessible class of common DNA sequence variants. Here, we propose to use advances in DNA sequencing and genotyping technology to more systematically evaluate the role of DNA sequence variation in susceptibility to age related macular degeneration. Our research team includes not only clinical expertise and understanding of macular degeneration but also expertise in high-throughput genetics and genomics and in the development and application of cutting edge statistical and computational methods. Through a combination of deep exome resequencing and low pass whole genome sequencing we propose to characterize genetic variation in 3,000 individuals and evaluate the contribution of >20M genetic variants to disease susceptibility, including not only common SNPs, but also rare SNPs, short insertion deletion polymorphisms, and larger copy number variants. Our approach should yield new susceptibility loci for macular degeneration and improve our understanding of the molecular mechanisms that contribute to disease susceptibility in previously implicated loci. PUBLIC HEALTH RELEVANCE: Age-related macular degeneration (AMD) is a progressive neurodegenerative disease and the major cause of blindness among the elderly. Loss of vision caused by macular degeneration is currently irreversible. Previous genetic studies of age-related macular degeneration focused on a class of easily accessible DNA sequence variants. We have assembled a team of experts in the clinical features of age related macular degeneration, in the methods and tools for the analysis of DNA sequence variation, and in associated computational problems and propose to more thoroughly assess the contribution of DNA sequence variation to disease susceptibility. We expect our research will lead to new disease susceptibility variants and better understanding of the molecular changes that lead to disease. This knowledge will facilitate development of new therapies and development of strategies for early diagnosis and prevention of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) INFORMATICS RESEARCH CENTER (IRC)
The AnVIL Data Ecosystem
  • 批准号:
    9598187
  • 项目类别:
  • 资助金额:
    $495.3万
  • 财政年份:
    2018
  • 负责人:
    Goncalo Abecasis
  • 依托单位:
Studies of Rare Genetic Variation in the Isolated Population of Sardinia
Studies of Rare Genetic Variation in the Isolated Population of Sardinia
海外基金